Literature DB >> 1125062

Enhancement of apomorphine-induced inhibition of striatal dopamine-turnover following chronic haloperidol.

G Gianutsos, M D Hynes, H Lal.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1125062     DOI: 10.1016/0006-2952(75)90177-x

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  10 in total

1.  The demonstration of a change in adrenergic receptor sensitivity in the central nervous system of mice after withdrawal from long-term treatment with haloperidol.

Authors:  R Dunstan; D M Jackson
Journal:  Psychopharmacology (Berl)       Date:  1976-07-09       Impact factor: 4.530

2.  Presynaptic dopamine receptors: insensitivity to kainic acid and the development of supersensitivity following chronic haloperidol.

Authors:  M J Bannon; E B Bunney; J R Zigun; L R Skirboll; R H Roth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-06       Impact factor: 3.000

3.  Presynaptic dopamine receptors. Development of supersensitivity following treatment with fluphenazine decanoate.

Authors:  M C Nowycky; R H Roth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-11       Impact factor: 3.000

4.  Dopaminergic supersensitivity: influence of dopamine agonists, cholinergics, anticholinergics, and drugs used for the treatment of tardive dyskinesia.

Authors:  A V Christensen; I M Nielsen
Journal:  Psychopharmacology (Berl)       Date:  1979-04-11       Impact factor: 4.530

5.  Lithium does not interact with haloperidol in the dopaminergic pathways of the rat brain.

Authors:  A Reches; V Jackson-Lewis; S Fahn
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

6.  Supersensitivity of dopamine-autoreceptors. The effect of gammabutyrolactone in long-term haloperidol treated rats.

Authors:  G Stock; J Steinbrenner; P Kummer
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

7.  Alterations in the effects of dopamine agonists and antagonists on general activity in rats following chronic morphine treatment.

Authors:  M L Smee; D H Overstreet
Journal:  Psychopharmacology (Berl)       Date:  1976-09-17       Impact factor: 4.530

8.  Increased effect of apomorphine on homovanillic acid in rats terminated from chronic haloperidol.

Authors:  R C Smith; N Narasimhachari; J M Davis
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

9.  Tolerance to fluphenazine and supersensitivity to apomorphine in central dopaminergic systems after chronic fluphenazine decanoate treatment.

Authors:  S C Wheeler; R H Roth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-06       Impact factor: 3.000

10.  Chronic gamma-butyrolactone (GBL) treatment: a potential model of dopamine hypoactivity.

Authors:  M C Nowycky; R H Roth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-11       Impact factor: 3.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.